Sunday, 4 October 2015

ResearchSpeak: ECTRIMS 2015

Are you ready for ECTRIMS 2015? #ECTRIMS #ReasearchSpeak #MSBlog #MSResearch

"I am sitting in the departure lounge at Heathrow ready to fly to Barcelona for the ECTRIMS 2015 meeting. Slight flutter of anxiety and anticipation; this meeting promises to the best ECTRIMS yet in relation to new data being presented. I am very excited about the ocrelizumab phase 3 data, both in the relapsing and primary progressive MS. Data will also be presented on baseline cognitive function as an important predictor of outcome; this will add impetus for incorporating cognitive  function testing into routine clinical practice. Follow-on data will be presented on the impact of alemtuzumab and other DMTs on end-organ damage (brain atrophy); the alemtuzumab brain atrophy data is possibly too good to be true."

"Barts-MS will be very active over the week; we promise to keep you all informed. I am looking forward to the launch of our policy document, that is trying  to shift the focus of MS treatment to focus on brain health, to stress that 'time matters' and to manage MS holistically. Hopefully all the questions and issues raised by our recent posts on early vs. delayed treatment will be addressed in the document. The next challenge is to get our neurology colleagues and other stakeholders to read the document and to get policymakers to adopt and implement the core principles being espoused."

"My diary is a sea of blue; I have never been busier at a meeting. I am not complaining it is all for a good cause, hopefully to make the lives of MSers and their families easier."


  1. "How to use social media to manage and research Multiple Sclerosis" D. Baker!

  2. Will you be able to release footage of the conference online?

  3. Is the Twitter interaction going to be available like last year?

  4. I took a look at the programme book yesterday and see your name associated with a number of presentations and posters. You have been a busy man - I hope you have your running shoes on to keep up with all the conference demands. I look forward to your updates as my time permits - I'm off to Washington for PCORI's annual meeting - the focus of which is patient focused research. I hope some of the patient voice comes out in ECTRIMS as well. safe travels!

  5. So excited -- lots of MS research rockstars on the roster! Hope everyone has a good trip over and thanks again for all you do!

  6. I'd be interested in knowing whether Roche are intending to apply for first-line use for ocrelizumab. But I'm guessing that'll be commercially confidential information.


Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.